v3.26.1
Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
$ in Millions
Total
Common stock
Treasury stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss) – net
Equity attributable to noncontrolling interests
Equity, beginning balance (in shares) at Dec. 31, 2024   457,000,000          
Equity, beginning balance at Dec. 31, 2024 $ 8,464 $ 5 $ (25) $ 6,583 $ 3,262 $ (1,379) $ 18
Treasury stock, beginning balance (in shares) at Dec. 31, 2024     0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of shares under equity awards, net of shares withheld for taxes and other (in shares)   1,000,000          
Issuance of shares under equity awards, net of shares withheld for taxes and other (11)     (11)      
Repurchase of common stock (in shares)     1,000,000        
Repurchase of common stock (100)   $ (100)        
Net income attributable to GE HealthCare 1,049       1,049    
Dividends declared (16)       (16)    
Other comprehensive income (loss) attributable to GE HealthCare 288         288  
Changes in equity attributable to noncontrolling interests 2           2
Share-based compensation 56     56      
Equity, ending balance (in shares) at Jun. 30, 2025   458,000,000          
Equity, ending balance at Jun. 30, 2025 9,733 $ 5 $ (125) 6,628 4,295 (1,090) 21
Treasury stock, ending balance (in shares) at Jun. 30, 2025     2,000,000        
Equity, beginning balance (in shares) at Mar. 31, 2025   458,000,000          
Equity, beginning balance at Mar. 31, 2025 9,207 $ 5 $ (25) 6,597 3,810 (1,199) 20
Treasury stock, beginning balance (in shares) at Mar. 31, 2025     0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of shares under equity awards, net of shares withheld for taxes and other $ (3)     (3)      
Repurchase of common stock (in shares) 1,400,000   1,000,000        
Repurchase of common stock $ (100)   $ (100)        
Net income attributable to GE HealthCare 486       486    
Other comprehensive income (loss) attributable to GE HealthCare 109         109  
Changes in equity attributable to noncontrolling interests 1           1
Share-based compensation 34     34      
Equity, ending balance (in shares) at Jun. 30, 2025   458,000,000          
Equity, ending balance at Jun. 30, 2025 $ 9,733 $ 5 $ (125) 6,628 4,295 (1,090) 21
Treasury stock, ending balance (in shares) at Jun. 30, 2025     2,000,000        
Equity, beginning balance (in shares) at Dec. 31, 2025 458,844,209 459,000,000          
Equity, beginning balance at Dec. 31, 2025 $ 10,390 $ 5 $ (225) 6,707 5,281 (1,388) 11
Treasury stock, beginning balance (in shares) at Dec. 31, 2025 3,107,626   3,000,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of shares under equity awards, net of shares withheld for taxes and other (in shares)   1,000,000          
Issuance of shares under equity awards, net of shares withheld for taxes and other $ (10)     (10)      
Repurchase of common stock (in shares) 4,700,000   5,000,000        
Repurchase of common stock $ (300)   $ (300)        
Net income attributable to GE HealthCare 950       950    
Dividends declared (32)       (32)    
Other comprehensive income (loss) attributable to GE HealthCare (92)         (92)  
Changes in equity attributable to noncontrolling interests 4           4
Share-based compensation $ 80     80      
Equity, ending balance (in shares) at Jun. 30, 2026 459,470,464 459,000,000          
Equity, ending balance at Jun. 30, 2026 $ 10,989 $ 5 $ (525) 6,776 6,199 (1,480) 14
Treasury stock, ending balance (in shares) at Jun. 30, 2026 7,785,199   8,000,000        
Equity, beginning balance (in shares) at Mar. 31, 2026   459,000,000          
Equity, beginning balance at Mar. 31, 2026 $ 10,680 $ 5 $ (325) 6,733 5,654 (1,398) 12
Treasury stock, beginning balance (in shares) at Mar. 31, 2026     5,000,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of shares under equity awards, net of shares withheld for taxes and other $ (1)     (1)      
Repurchase of common stock (in shares) 3,300,000   3,000,000        
Repurchase of common stock $ (200)   $ (200)        
Net income attributable to GE HealthCare 561       561    
Dividends declared (16)       (16)    
Other comprehensive income (loss) attributable to GE HealthCare (81)         (81)  
Changes in equity attributable to noncontrolling interests 2           2
Share-based compensation $ 45     45      
Equity, ending balance (in shares) at Jun. 30, 2026 459,470,464 459,000,000          
Equity, ending balance at Jun. 30, 2026 $ 10,989 $ 5 $ (525) $ 6,776 $ 6,199 $ (1,480) $ 14
Treasury stock, ending balance (in shares) at Jun. 30, 2026 7,785,199   8,000,000